-
Hongbaoli is expected to lose 3.2018 million in the first half of 2022, and the sales volume of rigid foam combination polyether decreases
Time of Update: 2022-11-04
Hongbaoli recently released the 2022 semi-annual performance forecast. During the reporting period, the net profit attributable to shareholders of the listed company was 3. 2018 million yuan, which tu
-
Zhejiang randomly checks 8 batches of melamine plastic tableware products
Time of Update: 2022-08-18
8 batches of melamine plastic tableware products from 8 companies in 4 regions, Quzhou and Taizhou, 0 batches failed, and the batch failure rate was 0% .
-
Running out of the "acceleration" of transformation and upgrading - the development record of Yuntianhua's annual production of 100,000 tons of wet-process phosphoric acid refining project
Time of Update: 2022-05-12
The first batch of refined phosphoric acid products has been sold and shipped, which provides a guarantee for Yuntianhua to develop new energy industry and is of great significance for the expansion of the fine phosphorus chemical industry cluster .
-
There are still many difficulties in the development of the domestic innovative drug industry, how to break the situation
Time of Update: 2021-10-10
In recent years, as the situation and policy environment have changed, innovation has become a necessary means for local pharmaceutical companies to develop upward . In this context, the research an
-
In early October, Guangdong Province will usher in a batch of price-cut drugs
Time of Update: 2021-09-28
According to the fifth batch of 61 countries’ centralized drug procurement (Guangdong), the selected products include ω-3 fish oil medium/long-chain fat emulsion injection, aripiprazole tablets, and esomeprazole sodium for injection.
-
The photovoltaic industry ushered in a new era of vigorous development
Time of Update: 2021-09-27
In 2020, under the huge impact of the global new crown pneumonia epidemic, the world's energy demand has seen an unprecedented drop, but the photovoltaic industry still maintains a rapid growth trend.
-
GSK's first-quarter results failed to meet expectations, and more anti-cancer drug investment will be reduced in the future
Time of Update: 2021-05-22
In the first quarter report, GSK revealed that due to the priority of its product portfolio, the company will abandon the phase I development plan of DMD's hematopoietic prostaglandin D2 synthase inhibitor GSK3439171 and the oncology drug candidate GSK3537142 in cooperation with Immunocore.
-
The first annual report of Anning shares: the market is improving, the production and sales growth promotes the leading operation of titanium ore, and the profit doubles
Time of Update: 2021-05-08
With the implementation of the quality improvement and efficiency project, the grade of Anning's vanadium-titanium iron concentrate products will be increased from 55% to 61% from 2020.
-
5 important issues facing the field of gene therapy in 2021
Time of Update: 2021-02-11
Vertex, a researcher and co-creator of CRISPR Therapeutics, showed that gene therapy using CRISPR-edited stem cells worked well in the top 10 patients treated with sickle cell disease or β thalassemia in two early studies.
-
From express products into the paint circle - dialogue AkzoNobel China and North Asia President Mr. Guo Zhenhua
Time of Update: 2020-11-03
In March, a "new" professional manager walked into AkzoNobel and into the Chinese paint industry, where he is Mr. Guo Zhenhua, who is currently president of AkzoNobel China and North Asia and managing director of the Decorative Paint China and North Asia Business Group guo is "new" because of his distinctive resume: Mr. Guo has held senior positions at several international and regional companies.
-
Summary of the most full CAR-T drug market approval
Time of Update: 2020-07-24
On June 6, 2020, Nanjing Legendary Bio was listed on NASDAQ, and CAR-T drug became a hot topic in the industry again And WHAT about the registration approval of CAR-T drugs in China? Below is the auth
-
Guizhou Province plans to lay out a blueprint for the development of new pharmaceutical industry
Time of Update: 2020-04-03
As a "sister chapter", the new pharmaceutical industry must have the same strength, level and effect as the big data industry This is the consensus reached at the new pharmaceutical industry developme
-
The IPO of vir biotechnology, which is dedicated to infectious diseases, fell nearly 30%, and hepatitis B may achieve functional cure
Time of Update: 2019-10-12
Virbiotechnology, founded in April 2016, is a clinical immunology company from California, USA, focusing on the treatment and prevention of infectious diseases Its mission is to create a world free of
-
Pharmaceutical industry as a whole callback industry differentiation trend
Time of Update: 2014-06-16
Source: on June 16, 2014, the growth rate of the pharmaceutical sector, which is famous for its high growth and defense, slowed down significantly in the second half of last year, both in performance
